Authors
Latest:
Testimonials Do Not Convert Patients From Brand to Generic MedicationWe conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.
Latest:
Increasing Pharmaceutical Copayments: Impact on Asthma Medication Utilization and OutcomesEven small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Latest:
Economic Implications of Weight Change in Patients With Type 2 Diabetes MellitusModest weight loss (>3%) among metformin-treated patients with type 2 diabetes mellitus was associated with decreased costs, lower resource utilization, and lower rates of treatment discontinuation.
Latest:
Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital SystemsSince 2015, the majority of new accountable care organizations (ACOs) have been led by physician groups rather than hospital systems. This shift requires policies that address the characteristic strengths and weaknesses of physician-led ACOs.
Latest:
Food Insecurity, Healthcare Utilization, and High Cost: A Longitudinal Cohort StudyIn a longitudinal study, the authors find that food insecurity is associated with greater emergency department visits, inpatient admissions, and length of stay. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Latest:
Service Setting Impact on Costs for Bevacizumab-Treated Oncology PatientsFor patients with lung or colorectal cancer, bevacizumab treatment patterns and healthcare costs varied by the setting of treatment initiation (physician office vs hospital outpatient).
Latest:
Cost-Effectiveness of DPP-4 Inhibitor and SGLT2 Inhibitor Combination Therapy for Type 2 DiabetesThis study evaluates the long-term cost-effectiveness of treatment involving combination therapy with dipeptidyl peptidase 4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors compared with an alternative with sulfonyureas prior to insulin initiation on a background of metformin.
Latest:
Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and RecommendationsThis review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.
Latest:
Cost Sharing for Antiepileptic Drugs: Medication Utilization and Health Plan CostsIncreased out-of-pocket costs for antiepileptic drugs were associated with decreased adherence, higher healthcare utilization, and higher spending among US commercial health plan beneficiaries with epilepsy.
Latest:
Cost Savings in Inpatient Oncology Through an Integrative Medicine ApproachAn approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.
Latest:
Sharing Care in the ACO EraThe authors propose a framework considering patient complexity and certainty of diagnosis to triage encounters to the most appropriate provider in an accountable care organization.
Latest:
Potential Misuse and Inappropriate Prescription Practices Involving Opioid AnalgesicsA quarter of opioid recipients with commercial insurance had at least 1 indicator of potential misuse by patients or inappropriate prescription practices by providers.
Latest:
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug AdherenceCommercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Latest:
Mometasone Furoate Versus Beclomethasone Dipropionate: Effectiveness in Patients With Mild AsthmaIn patients with mild asthma, mometasone furoate dry powder inhaler resulted in improved adherence and fewer exacerbations than beclomethasone dipropionate hydrofluoroalkane aerosol inhaler.
Latest:
Effects of an Integrated Medication Therapy Management Program in a Pioneer ACOThis article reports that an integrated medication management program in a Pioneer Accountable Care Organization was associated with decreases in all-cause hospitalization and Medicare costs.
Latest:
Genetic Counselors Save Costs Across the Genetic Testing SpectrumGenetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
Latest:
The Use of Claims Data Algorithms to Recruit Eligible Participants Into Clinical TrialsUsing an ICD-9-CM code algorithm, the authors effectively identified potentially difficult-to-reach populations for a hypertension clinical trial.
Latest:
What the Data Can-and Can't-Say About PatientsDr. Vojta emphasized the importance of analyzing existing good patient data to improve care outcomes.
Latest:
Process, Cost, and Clinical Quality: The Initial Oral Contraceptive VisitLinking variation in process with cost and quality provides the opportunity for identifying low-cost, high-quality processes.
